Cholestasis Reversal: Efficacy of IV Fish Oil

Status:
Completed

Trial end date:
2019-01-23

Target enrollment:

Participant gender:

The purpose of this study is to determine whether Omegaven is effective in the treatment of parenteral nutrition associated liver disease (PNALD).

Phase 2/Phase 3

Mark Puder